Biography

Emma Guilbaud is currently a Post-Doctoral Associate with the Galluzzi Lab, where she investigates the modulation of mitophagy as a therapeutic strategy to boost the immunostimulatory effects of radiation therapy in breast cancer. Prior to joining the Galluzzi Lab (2022), she was a Ph.D. student with the Yvan-Charvet and Ricci Labs in the Mediterranean Center of Molecular Medicine (Nice, France; 2018-2021) where she obtained her Ph.D. in Clinical and Therapeutic Research (2021), after receiving her B.Sc. (2016) in Molecular Biology and Genetics, and her M.Sc. (2018) in Genetics, Immunology and Animal Development from the University of Côte d’Azur (Nice, France). Emma has a long-standing interest in adaptive stress responses in cancer cells limiting the activation of antitumor immunity. 

(Co)-first Authored Publications

  1. Guilbaud, E. and L. Galluzzi. A mitochondrial checkpoint to NF-κB signaling. Cell Death Dis, 2024. 15(7): p. 477. 
  2. Guilbaud, E., Sarosiek, K. and L. Galluzzi. Inflammation and mitophagy are mitochondrial checkpoints to aging. Nat Commun, 2024. 15(1): p. 3375. 
  3. Holicek P., Guilbaud, E., Klapp, V., et al. Type I interferon and cancer. Immunol Rev, 2024. 321(1): p. 115-127.
  4. Guilbaud, E., Kroemer, G. and L. Galluzzi. Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell, 2023. 41(6):1014-1016. 
  5. Marchi, S., Guilbaud, E., Tait, S.W.G., Yamazaki, T. and L. Galluzzi. Mitochondrial control of inflammation. Nat Rev Immunol, 2023. 23(2) p. 159-173.
  6. Guilbaud, E. and L. Galluzzi. Adaptation to MOMP drives cancer persistence. Cell Res, 2023. 33(2): p. 93-94.
  7. Guilbaud, E., Yamazaki, T. and L. Galluzzi. T cell-independent abscopal responses to radiotherapy. Trends Cancer, 2023. 9(2): p. 93-95.
  8. Guilbaud, E., Spada, S., Bloy, N. et al. Quantitative assessment of mitophagy in irradiated cancer cells. Methods Cell Biol, 2023. 174: p. 93-111.  

Abstracts selected for Oral Presentation 

  1. Guilbaud, E., Sato, A. and L. Galluzzi. MOMP-dependent mitophagy limits radiotherapy-induced inflammation in breast cancer. Gordon Research Seminar Cell Death in Immunity, Inflammation and Disease (July 2024). 
  2. Guilbaud, E., Sato, A., Yamazaki, T. and L. Galluzzi. Targeting mitophagy to maximize the immunostimulatory effects of radiation therapy in ER+ breast cancer. Mitochondria in Aging, Cancer and Cell Death (November 2023). 

Abstracts Selected for Poster Presentation 

  1. Guilbaud, E., Sato, A. and L. Galluzzi. MOMP-dependent mitophagy limits radiotherapy-induced inflammation in breast cancer. Gordon Research Conference Harnessing Cell Death Mechanisms in Health and Disease (July 2024). 
  2. Guilbaud, E., Sato, A., Yamazaki, T. and L. Galluzzi. Targeting mitophagy to maximize the immunostimulatory effects of radiation therapy in ER+ breast cancer. Keystone Symposia Autophagy and Disease (December 2023).  
  3. Guilbaud, E., Sato, A., Yamazaki, T. and L. Galluzzi. Targeting mitophagy to maximize the immunostimulatory effects of radiation therapy in ER+ breast cancer. Keystone Symposia Mitochondria Signaling and Disease (February 2024).  
  4. Guilbaud, E., Sato, A. and L. Galluzzi. Targeting mitophagy to enhance radiotherapy-induced immune responses. Gordon Research Conference and Seminar Autophagy in Stress, Development and Disease (March 2024). 

Fellowships

  1. Philippe Foundation Scholarship (2023).

Other Achievements

  1. William Guy Forbeck Scholar Award Mitochondrial Stress in Cancer (2025).

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/emma.guilbaud.1/bibliography/public/